RM
RP Management Portfolio holdings
AUM
$139M
This Quarter Return
-24.7%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$179M
AUM Growth
+$179M
(-0.74%)
Cap. Flow
+$53.1M
Cap. Flow
% of AUM
29.71%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Cytokinetics
CYTK
|
$53.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biohaven
BHVN
$1.63B
| $102M | 57% |
2,936,507
| – | – |
|
|
2
Cytokinetics
CYTK
$4.23B
| $53.1M | 29.71% |
+980,392
| New | +$53.1M |
|
3
BioCryst Pharmaceuticals
BCRX
$1.74B
| $23.8M | 13.29% |
3,846,154
| – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2K | ﹤0.01% |
3,700
| – | – |
|